COVID-19: Vaccines and Therapeutics
The Department of Health and Human Services (HHS) March 19 updated its guidance to hospitals on the reporting of COVID-19-related data.
The Food and Drug Administration yesterday updated the health care provider fact sheets for all three monoclonal antibody therapies authorized for emergency use to include information on whether SARS-CoV-2 variants may show resistance to that therapy.
As part of AHA’s Joining Hands for Greater Impact series, we talk to Atrium Health, American Airlines and Charlotte Douglas International Airport representatives about how they came together to “get shots in arms” in Charlotte, N.C.
AHA’s Living Learning Network open house event will feature insight from UCLA Health leaders on successful strategies and creative solutions being used to efficiently and equitably accelerate the COVID-19 vaccine rollout, as well as lessons learned along the way. As marginalized populations have…
Recorded March 30, 2021
12-1 p.m. ET
The Food and Drug Administration launched a dashboard that will provide weekly updates on adverse events submitted to its adverse event reporting system for COVID-19 drugs and biological products authorized for emergency use.
President Biden March 11 signed into law the American Rescue Plan Act of 2021, a $1.9 trillion COVID-19 relief package, which includes a number of provisions that affect hospitals and health systems. A summary of provisions affecting hospitals and health systems follows.
Moderna announced the administration of first COVID-19 vaccine doses to participants between the ages of 6 months and 12 years old as part of a phase 2/3 clinical trial.
Medicare will nearly double what it pays to administer COVID-19 vaccines to about $40 per dose to better reflect the costs involved and help providers vaccinate more Americans, the Centers for Medicare & Medicaid Services announced today.
As urged by the AHA, the Centers for Medicare & Medicaid Services (CMS) today announced it is increasing the Medicare payment rates for COVID-19 vaccine administration.